Altimmune, Inc.ALTNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank57
3Y CAGR-20.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-20.6%/yr
vs -11.0%/yr prior
Acceleration
-9.6pp
Decelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 15.41% |
| 2024 | -5.26% |
| 2023 | -20.96% |
| 2022 | 30.74% |
| 2021 | -161.34% |
| 2020 | -260.80% |
| 2019 | 7.70% |
| 2018 | 48.95% |
| 2017 | -110.12% |
| 2016 | 6200.78% |